Case Report
Copyright ©2006 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Jul 28, 2006; 12(28): 4602-4603
Published online Jul 28, 2006. doi: 10.3748/wjg.v12.i28.4602
Branch retinal vein thrombosis and visual loss probably associated with pegylated interferon therapy of chronic hepatitis C
Luciana Lofego Gonçalves, Alberto Queiroz Farias, Patrícia Lofego Gonçalves, Elbio Antonio D’Amico, Flair José Carrilho
Luciana Lofego Gonçalves, Santa Casa de Misericórdia de Vitória, Espírito Santo, and University of Sao Paulo School of Medicine, Brazil
Alberto Queiroz Farias, Elbio Antonio D’Amico, Flair José Carrilho, University of Sao Paulo School of Medicine, Brazil
Patrícia Lofego Gonçalves, Federal University of Espírito Santo School of Medicine, Brazil
Correspondence to: Luciana Lofego Gonçalves, MD, Rua Inácio Higino 198/201, Vila Velha, ES, 29101-430, Brazil. lucianalofego@terra.com.br
Telephone: +55-27-32273855 Fax: +55-27-32273855
Received: January 19, 2006
Revised: January 12, 2006
Accepted: January 24, 2006
Published online: July 28, 2006
Abstract

Ophthalmological complications with interferon therapy are usually mild and reversible, not requiring the withdrawal of the treatment. We report a case of a patient who had visual loss probably associated with interferon therapy. Chronic hepatitis C virus infection (genotype 1a) was diagnosed in a 33-year old asymptomatic man. His past medical history was unremarkable and previous routine ophthalmologic check-up was normal. Pegylated interferon alpha and ribavirin were started. Three weeks later he reported painless reduction of vision. Ophthalmologic examination showed extensive intraretinal hemorrhages and cotton-wool spots, associated with inferior branch retinal vein thrombosis. Antiviral therapy was immediately discontinued, but one year later he persists with severely decreased visual acuity. This case illustrates the possibility of unpredictable and severe complications during pegylated interferon therapy.

Keywords: Hepatitis C; Interferon; Visual loss